« SAFC Completes High-Potency Fermentation Expansion in Israel | Main | More on G-men Looking into Foreign Drug Bribes »

10/06/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133f4e420ad970b

Listed below are links to weblogs that reference Medicare, Comparative Effectiveness and Reimbursement:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

k

In your opinion, would this eventually extend to group and/or individual insurance?

There are too many generic producers selling sub-therapeutic products (Mylan is usually the worst of what I get, but some of the Indian made products are quite bad). I suspect there a lot of dubious APIS in many of the "off brand" generics, and we all know the FDA lacks significant resources to oversee labs and manufacturers overseas.

Even with the Orange Book online, It takes a lot of time to track down what manufacturer makes both the brand and generic product (if possible), then finding a pharmacy who stocks (or will order) that brand for you. *sigh*

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada